News
Market and company headlines
The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy.

Accuray (ARAY) stock surged 42% premarket following a strategic CyberKnife imaging partnership with Samsung NeuroLogica.

Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.

Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing
2026-08-20. The following slide deck was published by Accuray Incorporated in conjunction with their 2026 Q4 earnings call.

Accuray Incorporated (ARAY) Q4 2026 Earnings Call August 19, 2026 4:30 PM EDTCompany ParticipantsStephen Monroe - Vice President of Financial Planning &...

Accuray (NASDAQ:ARAY) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

Fiscal Year 2027 Financial GuidanceAs the Company enters fiscal 2027, management believes Accuray is operating from a position of greater strength than a year ago. The Company expects continued growth in service

